ArticleInternational journal of hematology2021
Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma.
Hirohiko Shibayama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it